Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.851 | 0.120 | 17 | 34254988 | upstream gene variant | G/A;C | snv |
|
Infections; Musculoskeletal Diseases | 0.020 | 1.000 | 2 | 2014 | 2016 | ||||||||
|
0.732 | 0.280 | 17 | 34254422 | upstream gene variant | G/C | snv | 0.15 |
|
Neoplasms; Respiratory Tract Diseases | 0.020 | 1.000 | 2 | 2011 | 2016 | |||||||
|
0.925 | 0.120 | 17 | 34256892 | 3 prime UTR variant | C/T | snv | 0.28 |
|
Digestive System Diseases; Infections | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.925 | 0.120 | 17 | 34256892 | 3 prime UTR variant | C/T | snv | 0.28 |
|
Infections; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2020 | 2020 | |||||||
|
0.851 | 0.120 | 17 | 34254988 | upstream gene variant | G/A;C | snv |
|
Pathological Conditions, Signs and Symptoms; Infections | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.851 | 0.120 | 17 | 34254988 | upstream gene variant | G/A;C | snv |
|
Pathological Conditions, Signs and Symptoms; Infections | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.851 | 0.120 | 17 | 34254988 | upstream gene variant | G/A;C | snv |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||||
|
0.851 | 0.120 | 17 | 34254988 | upstream gene variant | G/A;C | snv |
|
Pathological Conditions, Signs and Symptoms; Infections | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.040 | 17 | 34256113 | non coding transcript exon variant | G/C | snv | 0.86 |
|
Musculoskeletal Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.732 | 0.280 | 17 | 34254422 | upstream gene variant | G/C | snv | 0.15 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.732 | 0.280 | 17 | 34254422 | upstream gene variant | G/C | snv | 0.15 |
|
Neoplasms | 0.010 | < 0.001 | 1 | 2016 | 2016 | |||||||
|
0.732 | 0.280 | 17 | 34254422 | upstream gene variant | G/C | snv | 0.15 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.732 | 0.280 | 17 | 34254422 | upstream gene variant | G/C | snv | 0.15 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.732 | 0.280 | 17 | 34254422 | upstream gene variant | G/C | snv | 0.15 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.732 | 0.280 | 17 | 34254422 | upstream gene variant | G/C | snv | 0.15 |
|
Neoplasms | 0.010 | < 0.001 | 1 | 2016 | 2016 | |||||||
|
0.732 | 0.280 | 17 | 34254422 | upstream gene variant | G/C | snv | 0.15 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.732 | 0.280 | 17 | 34254422 | upstream gene variant | G/C | snv | 0.15 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.732 | 0.280 | 17 | 34254422 | upstream gene variant | G/C | snv | 0.15 |
|
Nervous System Diseases; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.732 | 0.280 | 17 | 34254422 | upstream gene variant | G/C | snv | 0.15 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.732 | 0.280 | 17 | 34254422 | upstream gene variant | G/C | snv | 0.15 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.732 | 0.280 | 17 | 34254422 | upstream gene variant | G/C | snv | 0.15 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.776 | 0.240 | 17 | 34255979 | non coding transcript exon variant | AGCTCCTCCTTCTC/-;AGCTCCTCCTTCTCAGCTCCTCCTTCTC | delins | 0.33 |
|
Infections; Musculoskeletal Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.776 | 0.240 | 17 | 34255979 | non coding transcript exon variant | AGCTCCTCCTTCTC/-;AGCTCCTCCTTCTCAGCTCCTCCTTCTC | delins | 0.33 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.776 | 0.240 | 17 | 34255979 | non coding transcript exon variant | AGCTCCTCCTTCTC/-;AGCTCCTCCTTCTCAGCTCCTCCTTCTC | delins | 0.33 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.776 | 0.240 | 17 | 34255979 | non coding transcript exon variant | AGCTCCTCCTTCTC/-;AGCTCCTCCTTCTCAGCTCCTCCTTCTC | delins | 0.33 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 |